Literature DB >> 26945768

Pre-operative and post-operative cognitive deficits in patients with supratentorial meningiomas.

Kalyan Bommakanti1, Shanmukhi Somayajula2, Alladi Suvarna2, Aniruddh Kumar Purohit3, Shailaja Mekala2, Santoshi Kumari Chadalawadi2, Padmaja Gaddamanugu2.   

Abstract

OBJECTIVES: Cognitive deficits caused by extra-axial benign brain tumors like meningiomas and the course of these deficits after surgery is not well known. The aim of the study is to assess the pre-operative and post-operative cognitive functions in patients with meningiomas in the supratentorial compartment.
MATERIALS AND METHODS: In this prospective study, patients with clinico-radiological diagnosis of supratentorial meningioma, operated upon and later confirmed by histopathological examination, were included. The patients were evaluated for cognitive deficits before and after surgery. The various clinical and radiological factors influencing the cognitive status were evaluated.
RESULTS: A total of 57 patients were enrolled into the study. Out of 57, 22 were males and 35 were females. The frontal group had 22 patients, the parietal group had 10 patients, the temporal group had 10 patients, the occipital group had 6 patients, and the suprasellar group had 9 patients. Meningiomas, although extra-axial, caused significant cognitive deficits in 42 patients (73.7%). The highest frequency of cognitive deficits is seen in the frontal and temporal group of meningiomas (90% each). Frontal meningiomas with volume greater than 35 cc and peritumoral edema greater than 40 cc caused a higher frequency of cognitive deficits. Also, patients with raised ICP had significant cognitive deficits. Postoperatively there was a significant improvement in the cognitive functions in the frontal and temporal groups.
CONCLUSION: Meningiomas cause cognitive deficits in 73.7% of patients. Anatomical location of meningioma, elevated ICP, the volume of meningioma and extent of peritumoral edema significantly influence the incidence of cognitive deficits. Post-operatively, the cognitive deficits improve significantly in the frontal and temporal group.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cognitive; Meningioma; Post-operative

Mesh:

Year:  2016        PMID: 26945768     DOI: 10.1016/j.clineuro.2016.02.033

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  5 in total

1.  Risk of Developing Postoperative Deficits Based on Tumor Location after Surgical Resection of an Intracranial Meningioma.

Authors:  Jeff S Ehresman; Tomas Garzon-Muvdi; Davis Rogers; Michael Lim; Gary L Gallia; Jon Weingart; Henry Brem; Chetan Bettegowda; Kaisorn L Chaichana
Journal:  J Neurol Surg B Skull Base       Date:  2018-07-17

Review 2.  Visual field restoration after Simpson grade I resection of symptomatic occipital lobe meningioma: illustrative case and review of the literature.

Authors:  Marco V Corniola; Walid Bouthour; Maria-Isabel Vargas; Torstein R Meling
Journal:  Acta Neurochir (Wien)       Date:  2020-09-08       Impact factor: 2.216

3.  Cognitive outcomes in meningioma patients undergoing surgery: individual changes over time and predictors of late cognitive functioning.

Authors:  Sophie J M Rijnen; Ikram Meskal; Marjan Bakker; Wouter De Baene; Geert-Jan M Rutten; Karin Gehring; Margriet M Sitskoorn
Journal:  Neuro Oncol       Date:  2019-07-11       Impact factor: 12.300

4.  EANO guideline on the diagnosis and management of meningiomas.

Authors:  Roland Goldbrunner; Pantelis Stavrinou; Michael D Jenkinson; Felix Sahm; Christian Mawrin; Damien C Weber; Matthias Preusser; Giuseppe Minniti; Morten Lund-Johansen; Florence Lefranc; Emanuel Houdart; Kita Sallabanda; Emilie Le Rhun; David Nieuwenhuizen; Ghazaleh Tabatabai; Riccardo Soffietti; Michael Weller
Journal:  Neuro Oncol       Date:  2021-11-02       Impact factor: 13.029

5.  Clinical and Biological Correlates of Preoperative Cognitive Functioning of Glioma and Meningioma Patients.

Authors:  Aiste Pranckeviciene; Vytenis P Deltuva; Arimantas Tamasauskas; Jurate Zegliene; Adomas Bunevicius
Journal:  Biomed Res Int       Date:  2020-05-08       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.